U.S. President Donald Trump announced on Tuesday that he, along with a group of prominent artificial intelligence company leaders, had agreed to a voluntary accord that entails both internal and external reviews of the technology. Trump expressed satisfaction with the industry’s self-regulation efforts, emphasizing the importance of self-policing among AI developers.
The accord was reached following a meeting between Trump and executives from leading tech companies heavily investing in AI infrastructure. Concerns have been raised about the rapid development of AI technology, prompting some industry leaders to advocate for a more cautious approach. Despite these concerns, Trump reassured that the U.S. government would not impose restrictions on AI development, emphasizing its potential impact on society.
During the gathering at the White House, top AI executives such as Dario Amodei, Greg Brockman, Jeff Bezos, and Elon Musk, among others, engaged in discussions with Trump. The executives highlighted various perspectives on AI development, with some calling for increased safety measures and others emphasizing the need for responsible product management.
In a statement to the press following the meeting, Trump commended the AI industry for embracing self-regulation and pledged support for addressing community concerns related to the establishment of data centers. He hinted at the possibility of data centers becoming more prevalent but warned that resistance from local communities could lead companies to seek alternative locations.
Meanwhile, OpenAI CEO Sam Altman emphasized the company’s focus on safety measures and the importance of making informed decisions regarding AI model development. Altman’s remarks came after OpenAI paused the deployment of a new model due to safety considerations.
Geoffrey Hinton, a prominent figure in the AI field, expressed skepticism about Trump’s understanding of AI technology, likening the current AI landscape to owning a potentially dangerous pet. Hinton suggested that AI safety oversight in the U.S. should be regulated by a dedicated federal agency, drawing parallels to the FDA’s role in overseeing food and drug safety.
Trump positioned AI development as a global competition primarily between the U.S. and China, emphasizing the need for the U.S. to maintain its leadership in the AI sector. While acknowledging recent collaboration between the U.S. and China on AI-related matters, Trump underscored his preference for American leadership in the field.